Jubilant Pharmova Limited (JUBLPHARMA.BO)
INR 1087.85
(-0.13%)
INR 1087.85
(-0.13%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.18 Billion INR | 150.78% |
| 2022 | 2.06 Billion INR | -74.93% |
| 2021 | 8.25 Billion INR | -25.67% |
| 2020 | 11.1 Billion INR | -11.2% |
| 2019 | 12.5 Billion INR | -6.59% |
| 2018 | 13.38 Billion INR | 18.49% |
| 2017 | 11.29 Billion INR | 12.43% |
| 2016 | 10.04 Billion INR | 9.6% |
| 2015 | 9.16 Billion INR | 132.42% |
| 2014 | 3.94 Billion INR | -45.77% |
| 2013 | 7.27 Billion INR | -10.36% |
| 2012 | 8.11 Billion INR | 18.38% |
| 2011 | 6.85 Billion INR | 70.23% |
| 2010 | 4.02 Billion INR | -39.76% |
| 2009 | 6.68 Billion INR | 65.61% |
| 2008 | 4.03 Billion INR | -15.5% |
| 2007 | 4.77 Billion INR | 60.3% |
| 2006 | 2.97 Billion INR | 66.8% |
| 2005 | 1.78 Billion INR | -4.04% |
| 2004 | 1.86 Billion INR | 43.4% |
| 2003 | 1.29 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.98 Billion INR | 202.29% |
| 2024 Q1 | 655 Million INR | -61.56% |
| 2023 FY | 5.18 Billion INR | 150.78% |
| 2023 Q4 | 1.7 Billion INR | 38.09% |
| 2023 Q2 | 1.45 Billion INR | 81.73% |
| 2023 Q1 | 799 Million INR | 253.62% |
| 2023 Q3 | 1.23 Billion INR | -15.01% |
| 2022 Q3 | 516 Million INR | -58.65% |
| 2022 Q4 | -520.1 Million INR | -200.79% |
| 2022 FY | 2.06 Billion INR | -74.93% |
| 2022 Q1 | 978.3 Million INR | -33.36% |
| 2022 Q2 | 1.24 Billion INR | 27.57% |
| 2021 Q1 | 2.87 Billion INR | -0.41% |
| 2021 FY | 8.25 Billion INR | -25.67% |
| 2021 Q2 | 2.39 Billion INR | -16.53% |
| 2021 Q3 | 1 Billion INR | -57.91% |
| 2021 Q4 | 1.46 Billion INR | 45.48% |
| 2020 Q2 | 2.68 Billion INR | 164.07% |
| 2020 Q1 | 1.01 Billion INR | -75.54% |
| 2020 Q3 | 3.97 Billion INR | 48.17% |
| 2020 Q4 | 2.88 Billion INR | -27.42% |
| 2020 FY | 11.1 Billion INR | -11.2% |
| 2019 Q4 | 4.15 Billion INR | 25.77% |
| 2019 Q2 | 3.63 Billion INR | 6.52% |
| 2019 Q1 | 3.41 Billion INR | 33.17% |
| 2019 Q3 | 3.3 Billion INR | -9.28% |
| 2019 FY | 12.5 Billion INR | -6.59% |
| 2018 Q4 | 2.56 Billion INR | -39.48% |
| 2018 Q3 | 4.23 Billion INR | 16.28% |
| 2018 Q2 | 3.64 Billion INR | 1.52% |
| 2018 FY | 13.38 Billion INR | 18.49% |
| 2018 Q1 | 3.59 Billion INR | 20.07% |
| 2017 Q4 | 2.99 Billion INR | -11.59% |
| 2017 Q3 | 3.38 Billion INR | 44.46% |
| 2017 Q2 | 2.34 Billion INR | -13.9% |
| 2017 FY | 11.29 Billion INR | 12.43% |
| 2017 Q1 | 2.71 Billion INR | 13.17% |
| 2016 Q2 | 2.73 Billion INR | -9.2% |
| 2016 Q1 | 3 Billion INR | 78.69% |
| 2016 FY | 10.04 Billion INR | 9.6% |
| 2016 Q3 | 2.64 Billion INR | -3.28% |
| 2016 Q4 | 2.4 Billion INR | -9.08% |
| 2015 FY | 9.16 Billion INR | 132.42% |
| 2015 Q4 | 1.68 Billion INR | -28.03% |
| 2015 Q3 | 2.33 Billion INR | -7.33% |
| 2015 Q2 | 2.52 Billion INR | -2.38% |
| 2015 Q1 | 2.58 Billion INR | 87.84% |
| 2014 Q4 | 1.37 Billion INR | 23.1% |
| 2014 FY | 3.94 Billion INR | -45.77% |
| 2014 Q1 | 766.1 Million INR | -54.28% |
| 2014 Q2 | 682.3 Million INR | -10.94% |
| 2014 Q3 | 1.11 Billion INR | 63.95% |
| 2013 Q4 | 1.67 Billion INR | -7.96% |
| 2013 FY | 7.27 Billion INR | -10.36% |
| 2013 Q2 | 2.05 Billion INR | 16.95% |
| 2013 Q1 | 1.75 Billion INR | -2.64% |
| 2013 Q3 | 1.82 Billion INR | -11.4% |
| 2012 Q1 | -8.97 Billion INR | -564.83% |
| 2012 Q3 | 2.14 Billion INR | -1.2% |
| 2012 FY | 8.11 Billion INR | 18.38% |
| 2012 Q2 | 2.16 Billion INR | 124.14% |
| 2012 Q4 | 1.8 Billion INR | -15.74% |
| 2011 Q4 | 1.93 Billion INR | 22.05% |
| 2011 Q3 | 1.58 Billion INR | 0.0% |
| 2011 FY | 6.85 Billion INR | 70.23% |
| 2010 FY | 4.02 Billion INR | -39.76% |
| 2009 FY | 6.68 Billion INR | 65.61% |
| 2008 FY | 4.03 Billion INR | -15.5% |
| 2007 FY | 4.77 Billion INR | 60.3% |
| 2006 FY | 2.97 Billion INR | 66.8% |
| 2005 FY | 1.78 Billion INR | -4.04% |
| 2004 FY | 1.86 Billion INR | 43.4% |
| 2003 FY | 1.29 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 73.63% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -1034.099% |
| Sigachi Industries Limited | 1.47 Billion INR | -252.06% |
| Bal Pharma Limited | 233.9 Million INR | -2118.384% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -17.384% |
| Medico Remedies Limited | 100.3 Million INR | -5073.48% |
| Lasa Supergenerics Limited | -458 Million INR | 1232.957% |
| Venus Remedies Limited | 534.65 Million INR | -870.54% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 226.098% |
| Alpa Laboratories Limited | 184.49 Million INR | -2712.512% |
| Nectar Lifesciences Limited | 923.8 Million INR | -461.698% |
| Shilpa Medicare Limited | 1.36 Billion INR | -279.793% |
| Aarti Drugs Limited | 7.14 Billion INR | 27.414% |
| Lupin Limited | 28.04 Billion INR | 81.497% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 87.705% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 87.963% |
| Windlas Biotech Limited | 1.29 Billion INR | -299.495% |
| Suven Life Sciences Limited | -1.22 Billion INR | 523.308% |
| Eris Lifesciences Limited | 5.18 Billion INR | -0.14% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 63.67% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 234.678% |
| Ipca Laboratories Limited | 7.98 Billion INR | 34.98% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -321.527% |
| Achyut Healthcare Limited | 4.43 Million INR | -116822.037% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.025% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | -126.367% |
| Mankind Pharma Limited | 21.51 Billion INR | 75.885% |
| Laurus Labs Limited | 3.94 Billion INR | -31.414% |
| Piramal Pharma Limited | 4.55 Billion INR | -13.871% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1981.837% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.519% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 9.883% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 20.198% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -728.252% |
| Wanbury Limited | 569.71 Million INR | -810.805% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -12.617% |
| Wockhardt Limited | -670 Million INR | 874.478% |
| Themis Medicare Limited | 392.58 Million INR | -1221.739% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -921.195% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 42.211% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.339% |
| Divi's Laboratories Limited | 33.08 Billion INR | 84.314% |
| NATCO Pharma Limited | 25.96 Billion INR | 80.013% |
| Gufic Biosciences Limited | 1.32 Billion INR | -290.177% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -224.962% |
| Ind-Swift Limited | 1.22 Billion INR | -323.259% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -86.253% |
| FDC Limited | 2.98 Billion INR | -73.765% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 3514.782% |
| Granules India Limited | 6.81 Billion INR | 23.878% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 73.338% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -202.125% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -57118.785% |
| Brooks Laboratories Limited | 14.44 Million INR | -35834.903% |
| Megasoft Limited | -121.1 Million INR | 4384.747% |
| ZIM Laboratories Limited | 253.82 Million INR | -1944.29% |
| Strides Pharma Science Limited | 5.22 Billion INR | 0.704% |
| Neuland Laboratories Limited | 5.31 Billion INR | 2.427% |
| Morepen Laboratories Limited | 4.17 Billion INR | -24.322% |
| Hikal Limited | 32.11 Million INR | -16060.075% |
| Indoco Remedies Limited | 1.29 Billion INR | -301.455% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -65.883% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2394.112% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -18797.953% |
| Hester Biosciences Limited | 364.81 Million INR | -1322.384% |